ea0020p206 | Endocrine tumours and neoplasia | ECE2009
Nasoni Silvia
, Pacella Claudio Maria
, Bianchini Antonio
, Bizzarri Giancarlo
, Rossi Zaccaria
, Papini Enrico
, Misischi Irene
, Grimaldi Franco
Background: Liver metastases occur in about 4085% of patients with neuroendocrine tumours (NET). NET usually run a rather indolent course but the 5-year survival is about 40% in patients with liver metastases versus 7599% in subjects free of hepatic lesions. The most effective management and timing of treatment for patients with surgically unresectable metastases remains still unsettled.Purpose: To evaluate the feasibility, safety, and clinic...